Haemorrhagic cystitis (HC) is a relatively common complication of chemotherapy and radiotherapy to the pelvic area, but can be a challenging condition to treat, particularly since there is currently a lack of UK-led guidelines available on how it should optimally be defined and managed.
Materials and methods
A comprehensive literature search was undertaken to evaluate the evidence for the diagnosis, prevention and management of cancer treatment-induced HC.
Results
Recommendations and a proposed management algorithm for the diagnosis, prevention and treatment of HC, as well as the management of intractable haematuria, have been developed based on the expert opinion of the multidisciplinary consensus panel following a comprehensive review of the available clinical data.
Conclusion
These guidelines are relevant and applicable to current clinical practice and will help clinicians optimally define and manage this potentially serious condition.
EmadiA, JonesRJ, and BrodskyRA.Cyclophosphamide and cancer: Golden anniversary.Nat Rev Clin Oncol2009; 6: 638–647.
2.
ManikandanR, KumarS, and DorairajanLN.Hemorrhagic cystitis: A challenge to the urologist.Indian J Urol2010; 26: 159–166.
3.
LammD, PersadR, ColombelM.Maintenance Bacillus Calmette-Guerin: The standard of care for the prophylaxis and management of intermediate- and high-risk non-muscle-invasive bladder cancer.Eur Urol Suppl2010; 9: 715–734.
4.
HallMC, ChangSS, DalbagniG.Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.J Urol2007; 178: 2314–2330.
5.
DentonAS, Clarke, and MaherJ.Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis.Cochrane Database Syst Rev2002: CD001773.
6.
IsakaS, OkanoT, AbeK.Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer.Cancer Chemother Pharmacol1992; 30 (Suppl): S41–S44.
7.
WitjesJA, CarisCT, MunganNA.Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer.J Urol1998; 160: 1668–1671.
8.
CrawfordML, WallerPC, and WoodSM.Severe cystitis associated with tiaprofenic acid.Br J Urol1997; 79: 578–584.
9.
BuchbinderR, ForbesA, KobbenF.Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its development.J Clin Epidemiol2000; 53: 1013–1019.
10.
ChenCH, LeeMH, ChenYC.Ketamine-snorting associated cystitis.J Formos Med Assoc2011; 110: 787–791.
11.
FollandDS, KimbroughRD, ClineRE.Acute hemorrhagic cystitis. Industrial exposure to the pesticide chlordimeform.JAMA1978; 239: 1052–1055.
12.
DeckerDB, KaramJA, and WilcoxDT.Pediatric hemorrhagic cystitis.J Pediatr Urol2009; 5: 254–264.
13.
TsuboiK, KishiK, OhmachiK.Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.Bone Marrow Transplant2003; 32: 903–907.
14.
TangW, WangL, ZhaoWL.Intravenous busulfancyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.Biol Blood Marrow Transplant2011; 17: 1555–1561.
15.
CarpenterPA, MarshallGM, GiriN.Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.Bone Marrow Transplant1996; 18: 489–494.
16.
CesaroS, BrugioloA, FaraciM.Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: A survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group.Bone Marrow Transplant2003; 32: 925–931.
17.
PayneH, AdamsonA, BahlA.Chemical- and radiation-induced haemorrhagic cystitis: Current treatments and challenges.BJU Int. Epub ahead of print 13 June 2013.
HassanZ.Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children.Pediatr Transplant2011; 15: 348–361.
20.
ThompsonA, BahlA, BorwellJ.Current management and recommendation for guidance of cancer treatment-related cystitis: Results of surveys by the British Association of Urological Surgeons (BAUS), the British Uro-oncology Group (BUG), and the British Association of Urological Nurses (BAUN). In: 20th United Kingdom Continence Society Annual Scientific Meeting 2013, Bradford, UK, 17-19 April 2013, poster P13.
21.
GorczynskaE, TurkiewiczD, RybkaK.Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant2005; 11: 797–804.
22.
DrollerMJ, SaralR, and SantosG.Prevention of cyclophosphamide-induced hemorrhagic cystitis.Urology1982; 20: 256–258.
23.
BrugieresL, HartmannO, TravagliJP.Hemorrhagic cystitis following highdose chemotherapy and bone marrow transplantation in children with malignancies: Incidence, clinical course, and outcome.J Clin Oncol1989; 7: 194–199.
24.
BearmanSI, AppelbaumFR, BucknerCD.Regimenrelated toxicity in patients undergoing bone marrow transplantation.J Clin Oncol1988; 6: 1562–1568.
CoxPJ.Cyclophosphamide cystitis - identification of acrolein as the causative agent.Biochem Pharmacol1979; 28: 2045–2049.
27.
Wong-You-CheongJJ, WoodwardPJ, ManningMA.From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: Radiologic-pathologic correlation.Radiographics2006; 26: 1847–1868.
28.
VilarDG, FadriqueGG, MartinIJ.Hyperbaric oxygen therapy for the management of hemorrhagic radio-induced cystitis [in English and Spanish].Arch Esp Urol2011; 64: 869–874.
29.
ShaoY, LuGL, and ShenZJ.Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis.BJU Int2012; 109: 691–694.
30.
LawsonM, VasilarasA, De VriesA.Urological implications of cyclophosphamide and ifosfamide.Scand J Urol Nephrol2008; 42: 309–317.
31.
BallenKK, BeckerP, LevebvreK.Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.Oncology1999; 57: 287–292.
32.
TrotmanJ, Nivison-SmithI, and DoddsA.Haemorrhagic cystitis: Incidence and risk factors in a transplant population using hyperhydration.Bone Marrow Transplant1999; 23: 797–801.
33.
TurkeriLN, LumLG, UbertiJP.Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: Role of continuous bladder irrigation.J Urol1995; 153 (3 Pt 1): 637–640.
34.
AtkinsonK, BiggsJC, GolovskyD.Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients.Bone Marrow Transplant1991; 7: 351–354.
ShepherdJD, PringleLE, BarnettMJ.Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.J Clin Oncol1991; 9: 2016–2020.
37.
FrustaciS, FoladoreS, De PascaleA.Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO).Ann Oncol1992; 3 (Suppl 2): S115–S118.
38.
LetendreL, HoaglandHC, and GertzMA.Hemorrhagic cystitis complicating bone marrow transplantation.Mayo Clin Proc1992; 67: 128–130.
39.
VoseJM, ReedEC, PippertGC.Mesna compared with continuous bladder irrigation as uroprotection during highdose chemotherapy and transplantation: A randomized trial.J Clin Oncol1993; 11: 1306–1310.
40.
MurphyC, HardenE, StevensD.The addition of mesna to hyperhydration does not decrease the incidence of hemorrhagic cystitis in patients receiving highdose cyclophosphamide.Oncol Rep1994; 1: 265–266.
41.
KatzA, EpelmanS, AnelliA.A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: Sustained efficiency and simplified administration.J Cancer Res Clin Oncol1995; 121: 128–131.
42.
KhojastehNH, ZakeriniaM, RamziM.A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients.Transplant Proc2000; 32: 596.
43.
MaceJR, KeohanML, BernardyH.Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with highdose ifosfamide.Clin Cancer Res2003; 9: 5829–5834.
44.
HowsJM, MehtaA, WardL.Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: A prospective randomised study.Br J Cancer1984; 50: 753–756.
45.
MiodoskyM, Abdul-HaiA, TsirigotisP.Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate.Bone Marrow Transplant2006; 38: 507–511.
46.
KallestrupEB, JorgensenSS, NordlingJ.Treatment of interstitial cystitis with Cystistat: A hyaluronic acid product.Scand J Urol Nephrol2005; 39: 143–147.
47.
MoralesA, EmersonL, NickelJC.Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.Urology1997; 49 (5A Suppl): 111–113.
48.
Gonzalez PatinoE, Salvador GarridoN, Cascallar CanedaL.Protective effect on the urinary bladder mucosa of intravesical hyaluronic acid in cervix cancer patients treated with pelvic radiotherapy, weekly chemotherapy and highdose rate brachytherapy.Brachytherapy2008; 7: 152–153.
49.
Samper OtsPM, Lopez CarrizosaC, RodriguezA.Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by highdose brachytherapy do not affect the survival: A five-year follow-up study.Clin Transl Oncol2009; 11: 828–834.
50.
DelgadoJM, SamperP, and GarridoJ.Hyaluronic acid in the prevention of radiation-induced cystitis (Abstr.).Proc Am Soc Clin Oncol2003; 22: 752.
51.
BonettaA, and Di PierroF.Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma.Cancer Manag Res2012; 4: 281–286.
52.
CowanCC, HutchisonC, ColeT.A randomized double-blind placebo-controlled trial to determine the effect of cranberry juice on decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing radiotherapy for cancer of the bladder or cervix.Clin Oncol (R Coll Radiol)2012; 24: 31–38.
53.
CampbellG, PicklesT, and D'YachovaY.A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer.Clin Oncol (R Coll Radiol)2003; 15: 322–328.
54.
HazewinkelMH, StalpersLJ, DijkgraafMG.Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies.Int Urogynecol J2011; 226: 725–730.
55.
ChoongSKS, WalkdenM, andR.Kirby The management of intractable haematuria.BJU Int2000; 86: 951–959.
56.
SommarivaML, SandriSD, and CerianiV.Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis.Minerva Urol Nefrol2010; 62: 145–150.
57.
NordlingJ, and van OphovenA.Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multicentre, prospective observational clinical trial.Arzneimittelforschung2008; 58: 328–335.
58.
IppolitiC, PrzepiorkaD, MehraR.Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation.Urology1995; 46: 811–815.
59.
LevineLA, and JarrardDF.Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.J Urol1993; 149: 719–723.
60.
DemirHA, Savaş ŞenZ, AltuğMU.Successful treatment of cyclophosphamide-induced haemorrhagic cystitis with intravesical prostaglandin E1 in a child with non-Hodgkin's lymphoma.Scand J Urol Nephrol2011; 45: 281–284.
61.
MiuraM, SasagawaI, KubotaY.Effective hyperbaric oxygenation with prostaglandin E1 for radiation cystitis and colitis after pelvic radiotherapy.Int Urol Nephrol1996; 28: 643–647.
62.
YamamotoM, HibiH, OhmuraM.Successful treatment of hemorrhagic cystitis secondary to cyclophosphamide chemotherapy with intravesical instillation of prostaglandin F2 alpha.Hinyokika Kiyo1994; 40: 833–835.
63.
HemalAK, PraveenBV, SankaranarayananA.Control of persistent vesical bleeding due to radiation cystitis by intravesical application of 15 (S) 15-methyl prostaglandin F2-alpha.Indian J Cancer1989; 26: 99–101.
64.
LojanapiwatB, SripralakritS, SoonthornphanS.Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis.Asian J Surg2002; 25: 232–235.
65.
DewanAK, MohanGM, and RaviR.Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix.Int J Gynaecol Obstet1993; 42: 131–135.
66.
VicenteJ, RiosG, and CaffarattiJ.Intravesical formalin for the treatment of massive hemorrhagic cystitis: Retrospective review of 25 cases.Eur Urol1990; 18: 204–206.
67.
HoCC, and Md ZainuddinZ.Alum irrigation for the treatment of intractable haematuria.Malays J Med Sci2009; 16: 66–68.
68.
EfrosMD, AhmedT, CoombeN.Urologic complications of highdose chemotherapy and bone marrow transplantation.Urology1994; 43: 355–360.
69.
ArrizabalagaM, ExtramianaJ, ParraJL.Treatment of massive haematuria with aluminium salts.Br J Urol1987; 60: 223–226.
70.
BogrisSL, JohalNS, HusseinI.Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the literature.J Pediatr Hematol Oncol2009; 31: 285–288.
71.
KanwarVS, JenkinsJJ3rd, MandrellBN.Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis.Med Pediatr Oncol1996; 27: 64–67.
72.
SeearMD, DimmickJE, and RogersPC.Acute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis.Urology1990; 36: 353–354.
73.
NakadaT, NakadaH, YoshidaY.Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: A longterm follow-up study.Urol Int2012; 89: 208–214.
74.
OliaiC, FisherB, JaniA.Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis.Int J Radiat Oncol Biol Phys2012; 84: 733–740.
ChongKT, HampsonNB, and CormanJM.Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis.Urology2005; 65: 649–653.
77.
BeversRF, BakkerDJ, and KurthKH.Hyperbaric oxygen treatment for haemorrhagic radiation cystitis.Lancet1995; 346: 803–805.
78.
BuiQC, LieberM, WithersHR.The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects.Int J Radiat Oncol Biol Phys2004; 60: 871–878.
79.
CormanJM, McClureD, PritchettR.Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen.J Urol2003; 169: 2200–2202.
80.
Del PizzoJJ, ChewBH, JacobsSC.Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: Long-term followup.J Urol1998; 160 (3 Pt 1): 731–733.
81.
DavisM, MacDonaldH, SamesC.Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen.N Z Med J2011; 124: 48–54.
82.
Ajith KumarS, PrasanthP, TripathiK.Hyperbaric oxygen - A new horizon in treating cyclophosphamide-induced hemorrhagic cystitis.Indian J Urol2011; 27: 272–273.
83.
Kalayoğlu-BeşişikS, Abdul-RahmanIS, ErerB.Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis.J Urol2003; 170: 922.
84.
ZamaD, MasettiR, VendeminiF.Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients.Pediatr Transplant2013; 17: 86–91.
85.
TorenPJ, and NormanRW.Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulphate.J Urol2005; 173: 103.
86.
HampsonSJ, and WoodhouseCR.Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: Experience with 14 patients.Eur Urol1994; 25: 40–42.
87.
DuthieG, WhyteL, ChandranH.Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: Improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapy.J Pediatr Surg2012; 47: 375–379.
88.
HeathJA, MishraS, MitchellS.Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation.Bone Marrow Transplant2006; 37: 523–526.
89.
OrdemannR, NaumannR, GeisslerG.Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature.Bone Marrow Transplant2000; 25: 981–985.
90.
MillerJ, BurfieldGD, and MorettiKL.Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis.J Urol1994; 151: 1348–1350.
91.
LiuYK, HartyJI, SteinbockGS.Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen.J Urol1990; 144: 41–43.
92.
KarimiM, ZakeriniaM, KhojastehHN.Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation.J Thromb Haemost2004; 2: 1853–1855.
93.
DemesmayK, TissotE, BulaboisCE.Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: A report of four cases.Transplantation2002; 74: 1190–1192.
94.
PihuschM, BacigalupoA, SzerJ.Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation.J Thromb Haemost2005; 3: 1935–1944.
95.
GeislerJP, LinnemeierGC, and ManahanKJ.Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: A case report.J Reprod Med2008; 53: 360–362.
96.
ConnollySS, D'ArcyFT, and CorcoranMO.Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis.Ir J Med Sci2010; 179: 431–433.
97.
SinghI, and LaunganiGB.Intravesical epsilon aminocaproic acid in management of intractable bladder haemorrhage.Urology1992; 40: 227–229.
98.
LakhaniA, RaptisA, FrameD.Intravesicular instillation of E-aminocaproic acid for patients with adenovirusinduced hemorrhagic cystitis.Bone Marrow Transplant1999; 24: 1259–1260.
99.
PranikoffK, and ConstantinoG.The use of amitriptyline in patients with urinary frequency and pain.Urology1998; 51 (5A Suppl): 179–181.
100.
van OphovenA, PokupicS, HeineckeA.A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.J Urol2004; 172: 533–536.
101.
van OphovenA, and HertleL.Long-term results of amitriptyline treatment for interstitial cystitis.J Urol2005; 174: 1837–1840.
102.
FosterHEJr, HannoPM, NickelJC.Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome.J Urol2010; 183: 1853–1858.
103.
SoucyF, and GregoireM.Efficacy of prednisone for severe refractory ulcerative interstitial cystitis.J Urol2005; 173: 841–843.
104.
SeshadriP, EmersonL, and MoralesA.Cimetidine in the treatment of interstitial cystitis.Urology1994; 44: 614–616.
105.
ChoCL, LaiMH, SoHS.Superselective embolisation of bilateral superior vesical arteries for management of haemorrhagic cystitis.Hong Kong Med J2008; 14: 485–488.
106.
GineE, RoviraM, RealI.Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries.Bone Marrow Transplant2003; 31: 923–925.
